Kaminari Medical logo

Kaminari Medical

PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health impairing re-catheterizations In 2015, Coronary Artery Disease (CAD) affected 110 million people and resulted in 8.9 million deaths worldwide. CAD occurs when the arteries that supply the heart muscle with blood become hardened and narrowed, due to the buildup of cholesterol and plaque on their inner walls. Current treatment: To open the blocked coronary arteries, 80% of the patients are treated using a Percutaneous Coronary Intervention (PCI). - Of those patients treated with PCI, 12% get a re-catheterization within 12 months after the initial procedure. - Total costs for these re-catheterizations are estimated at $ 3,5 billion. 50% of these re-catheterizations are caused by a type of stenosis called vulnerable plaques, that are formed by fat-filled cells with a thin cover. If the cover ruptures a blood clot is formed, blocking the coronary artery. - If these vulnerable plaques were treated in an early stage, repeat catheterizations could be prevented. SOLUTION Kaminari combines ultrasound (IVUS) and photoacoustic (PA) imaging, providing better information on both plaque location and composition. Visit our website for more details.

Growth Trajectory

With recent funding, the company is poised to expand its clinical evidence, further develop its catheter for patient use, and enter the market. They aim to improve outcomes for millions of patients and transform cardiovascular diagnostics and therapy guidance through continued innovation in intravascular imaging.

Technical Challenges

Improving detection of high-risk plaques.
Developing catheter for eventual use in patients.

Tech Stack

Team Size

Key Risks

Requires development of clinical evidence to support product adoption.
Faces competition from existing diagnostic tools.
Market adoption may be hindered by the need to integrate with existing diagnostic and treatment strategies.

Opportunities

Address the unmet need in cardiovascular care for visualizing lipid-rich plaques.
Leverage the combination of IVPA and IVUS imaging for enhanced diagnostic capabilities.
Expand market presence through partnerships with healthcare institutions and research centers.
Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats